Leonhardt’s Launchpads Announces Partnership with Prizm Medical for Treatments Via Bioelectric Stimulation

Leonhardt’s Launchpads, an innovation and startup accelerator with operations in California and Utah announced today a partnership with Prizm Medical and its affiliated Weartech Therapeutics to collaborate in developing, testing and commercializing a number organ regeneration and recovery products.

Leonhardt’s Launchpads operated by Cal-X Stars Business Accelerator, Inc. in California and Leonhardt’s Launchpads Utah, Inc. in Utah has patented and has patented pending organ regeneration and recovery technologies based on bioelectric signaling control of stem cell homing and differentiation as well as controlled release of regeneration promoting proteins.  For severe disease cases this is combined with a micro infusion pump and repeat delivery of a stem cell + growth factor based regeneration composition with up to fifteen components including amniotic fluid, selected exosomes, PRF and nutrient hydrogel.

Prizm Medical and it’s affiliated Weartech Therapeutics have developed and brought to market with FDA 510K market clearance a full lineup of portable wearable electrical stimulation devices and intelligent conductive garments including knee wraps, socks, skin face masks, hair head helmets, gloves and full body tights.

Leonhardt’s Launchpads organ specific focused startups will employ its proprietary and patented bioelectric signaling platform in combination with Prizm Medical’s portable wearable stimulators and Weartech Therapeutics intelligent conductive garments to treat disease states that do not require an implantable device or do not require a high precision bench top stimulator in a clinic, where patients can have at home treatments.

Examples of combined applications under consideration include the following:

• Vasustim www.vascustim.com plans to use Prizm Medical’s wearable stimulator and conductive wraps and socks to treat diabetic foot and leg ulcers after patients receive high fidelity bioelectric treatments 2X per week at a clinic and in some cases, where permitted via regulatory pathways, also treatments with stem cells, growth factors, PRF, nutrient hydrogel, exosomes, Micro RNAs, matrix and amniotic fluid membranes.   The portable at home treatments with the Prizm Medical products is expected to enhance and accelerate healing.  Clinical trials of this combination are in planning stages now.
• OrthoStim www.ortho-stim.com plans to use a similar combination as above for treating degenerated joints.
• Skin-Stim www.skin-stim.com plans to use a similar combination as above for facial and neck skin regeneration.
• CerebraCell www.cerebracell.com plans to use a similar combination as above for stroke and brain injury recovery.
• DentaCell Accelerator – www.dentacellaccelerator.com plans to use a similar combination for dentistry applications.
• OrthodontiCell – www.orthodonticell.com plans to use a similar combination for orthodontic accelerated tooth movement and stabilization.

“The wearable portability that the Prizm Medical and Weartech Therapeutics products bring us is exactly what our patients and clinicians demanded to reduce time needed to be in clinics for treatment sessions.  We are really excited about what this partnership means in particular to our patients quality of life”.  states Dr. Leslie Miller Chief Medical Officer for Leonhardt’s Launchpads

“The Leonhardt team has a proven track record of bringing products from concept to market leadership and eventually to successful exit.  We are particularly impressed with the quality of the research collaborators and large Scientific Advisory Board comprising more  than 35 opinion leading clinicians and scientists in the field of regenerative medicine and organ recovery.”  stated Jim Johnson, President & CEO of Prizm Medical;

About Leonhardt’s Launchpads:

Leonhardt’s Launchpads by Cal-X Stars Business Accelerator, Inc. www.lventuresnestg.wpenginepowered.comand www.calxstars.com opened up in 2008 in Northern California, in 2013 in Los Angeles and in 2015 in Utah as the innovation and startup accelerator arm of Leonhardt Ventures LLC.  Leonhardt Ventures LLC (H.J. Leonhardt & Co. and formerly Leonhardt Vineyards LLC DBA Leonhardt Ventures) has been developing and bringing to market medical devices and biologics since the 1980’s.  In the 1980’s they patented and developed a unique cardiovascular balloon catheter line. In the 1990s the world’s leading stent graft for aortic aneurysm repair and the first percutaneous heart valve. In the 2000’s they innovated and brought to clinic some of the first stem cell therapies for organ regeneration. In 2001 Leonhardt led a team that completed the landmark first ever non-surgical stem cell repair of human heart. Since 2010 the research focus has been on the combination of bioelectric signaling, a re-fillable micro infusion pump and a mixed composition for organ regeneration. 30 organ specific startups are in the current portfolio class.  The accelerator business model is to advance each organ specific therapy through first-in-man clinical study results and then seek to secure a strategic partner.  In Utah they operate as Leonhardt’s Launchpads Utah, Inc. with a research laboratory at USTAR’s BioInnovations Gateway in Salt Lake City.

About Prizm Medical: 

Prizm Medical, Inc. and Weartech Therapeutics based Buford, Georgia, is the premier developer and manufacturer of electrotherapy devices for therapeutic pain management, increased blood circulation, improve range of motion, and retardation of disuse atrophy (muscle wasting).  Our company is FDA/GMP and ISO13483/2003 Certified. Prizm Medical, Inc. has provided our devices over the past ten years treating greater than 200,000 patients worldwide. The company has developed and patented the world’s first innovative garment electrodes “Intelligent Textiles for Medicine™”; Electro-Mesh™ garment electrodes, Silver-Thera™ Stocking electrodes, and the Stim-Support™ orthopedic products. Our vast array of garment electrodes are powered by the Micro-Z™ and the Micro-Z Mini™ are high volt pulsed galvanic neuromuscular and pain (TENS) stimulator which affords increased micro-circulation. By increasing micro-circulation to treat acute and chronic injuries, our products accelerate the body’s own natural healing process.  international registered trade mark:  “Intelligent Textiles for Medicine(R)”  Websites: www.prizm-medical.com; www.legandfootpain.com; www.weartechit.com; new website soon to be launch: www.woundstim.com. Prizm Medical, Inc. and WearTech Therapeutics, Inc., 940 Sherwin Pkwy, Suite 100, Buford, Ga. 30518.  Niine FDA 510ks , 20 published studies, CE-Certication and market approvals in the EU, Japan and Canada

Forward-Looking Statements:

This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to our growth strategy and product development programs and any other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; our dependence on third-party suppliers; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our Private Placement Memorandum 506D and 506D part C filings. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

Contact:

Brian@leonhardtventures.com Brian Hardy, Director of Marketing

Leonhardt’s Launchpads by Cal-X Stars, 12655 W Jefferson Blvd, Los Angeles, CA 90066

Leonhardt’s Launchpads Utah, Inc. 370 S, 300 E, Salt Lake City, UT 84111 Research Lab @ 2500 S State St. #224, Salt Lake City, UT 84115

Leonhardt Ventures LLC, 12760 Millennium Dr. Unit 213, Playa Vista, CA 90094

Leonhardt’s Launchpads Announces Partnership with Prizm Medical